These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12957269)

  • 1. Selective targeting of homologous DNA recombination repair by gemcitabine.
    Wachters FM; van Putten JW; Maring JG; Zdzienicka MZ; Groen HJ; Kampinga HH
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):553-62. PubMed ID: 12957269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-joining deficiency and radiosensitization induced by gemcitabine.
    van Putten JWG ; Groen HJM ; Smid K; Peters GJ; Kampinga HH
    Cancer Res; 2001 Feb; 61(4):1585-91. PubMed ID: 11245469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis.
    Grégoire V; Beauduin M; Bruniaux M; De Coster B; Octave Prignot M; Scalliet P
    Int J Radiat Biol; 1998 May; 73(5):511-20. PubMed ID: 9652808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug metabolism and homologous recombination repair in radiosensitization with gemcitabine.
    Im MM; Flanagan SA; Ackroyd JJ; Shewach DS
    Radiat Res; 2015 Jan; 183(1):114-23. PubMed ID: 25564718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine as a radiosensitizer in undifferentiated tumors.
    Kal HB; El Sharouni SY; Barten-van Rijbroek AD
    Anticancer Res; 2006; 26(1A):139-45. PubMed ID: 16475690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.
    Weiss C; Grabenbauer GG; Sauer R; Distel L
    Strahlenther Onkol; 2003 Feb; 179(2):93-8. PubMed ID: 12590319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants.
    Asaad NA; Zeng ZC; Guan J; Thacker J; Iliakis G
    Oncogene; 2000 Nov; 19(50):5788-800. PubMed ID: 11126366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
    Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
    Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.
    Yang LY; Li L; Jiang H; Shen Y; Plunkett W
    Clin Cancer Res; 2000 Mar; 6(3):773-81. PubMed ID: 10741696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs.
    Rosier JF; Michaux L; Ameye G; Cedervall B; Libouton JM; Octave-Prignot M; Verellen-Dumoulin C; Scalliet P; Grégoire V
    Mutat Res; 2003 Jun; 527(1-2):15-26. PubMed ID: 12787910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of mouse jejunum radiosensitization by 2',2'-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells.
    Grégoire V; Beauduin M; Rosier JF; De Coster B; Bruniaux M; Octave-Prignot M; Scalliet P
    Br J Cancer; 1997; 76(10):1315-21. PubMed ID: 9374377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM
    Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation enhancement of gemcitabine in two human squamous cell carcinoma cell lines.
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Damrau M; Ramm U; Rahn A; Böttcher HD
    Anticancer Res; 2000; 20(1A):401-5. PubMed ID: 10769687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanistic study of radiosensitization by gemcitabine on human squamous carcinoma cell line of the cervix].
    Miao JW; Kong WM; Zhang WH; Niu JW; Deng XH
    Zhonghua Fu Chan Ke Za Zhi; 2004 May; 39(5):342-5. PubMed ID: 15196420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine.
    Im MM; Flanagan SA; Ackroyd JJ; Knapp B; Kramer A; Shewach DS
    Radiat Res; 2016 Nov; 186(5):466-477. PubMed ID: 27740890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine].
    Mose S; Karapetian M; Jüling-Pohlit L; Taborski B; Ramm U; Damrau M; Rahn A; Böttcher HD
    Strahlenther Onkol; 1999 Feb; 175(2):78-83. PubMed ID: 10065143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin.
    Crul M; van Waardenburg RC; Bocxe S; van Eijndhoven MA; Pluim D; Beijnen JH; Schellens JH
    Biochem Pharmacol; 2003 Jan; 65(2):275-82. PubMed ID: 12504803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair.
    Kausar T; Schreiber JS; Karnak D; Parsels LA; Parsels JD; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
    Neoplasia; 2015 Oct; 17(10):757-66. PubMed ID: 26585231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil.
    Haveman J; Castro Kreder N; Rodermond HM; van Bree C; Franken NA; Stalpers LJ; Zdzienicka MZ; Peters GJ
    Oncol Rep; 2004 Jul; 12(1):187-92. PubMed ID: 15201982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation enhancement by gemcitabine-mediated cell cycle modulations.
    Mose S; Class R; Weber HW; Rahn A; Brady LW; Böttcher HD
    Am J Clin Oncol; 2003 Feb; 26(1):60-9. PubMed ID: 12576927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.